Scientists find immunotherapy anti-CTLA-4 extends life of mice with glioblastoma and discover new way cells kill cancer

Scientists have found the immunotherapy treatment anti-CTLA-4 leads to considerably greater survival of mice with glioblastoma. Furthermore, they discovered that this therapy was dependent on immune cells called CD4+ T cells infiltrating the brain and triggering the tumor-destructive activities of other immune cells called microglia, which permanently reside in the brain.

Read more
Enable notifications of new posts OK No thanks